Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tectonic Therapeutic (TECX) Cash & Current Investments (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Cash & Current Investments data on record, last reported at $236.9 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 22.65% to $236.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was $236.9 million, a 22.65% decrease, with the full-year FY2025 number at $254.4 million, up 80.11% from a year prior.
  • Cash & Current Investments reached $236.9 million in Q1 2026 per TECX's latest filing, down from $254.4 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for TECX hit a ceiling of $306.2 million in Q1 2025 and a floor of $6.6 million in Q3 2023.
  • A 5-year average of $146.2 million and a median of $141.2 million in 2024 define the central range for Cash & Current Investments.
  • Peak YoY movement for Cash & Current Investments: tumbled 94.32% in 2023, then soared 2305.79% in 2024.
  • Tracing TECX's Cash & Current Investments over 5 years: stood at $92.8 million in 2022, then crashed by 68.71% to $29.1 million in 2023, then skyrocketed by 386.16% to $141.2 million in 2024, then skyrocketed by 80.11% to $254.4 million in 2025, then decreased by 6.88% to $236.9 million in 2026.
  • Business Quant data shows Cash & Current Investments for TECX at $236.9 million in Q1 2026, $254.4 million in Q4 2025, and $269.0 million in Q3 2025.